Similarly, high ALDH3A1 expression has been linked to chemoresistance in paclitaxel plus gemcitabine-resistant pancreatic cancer cells, possibly by modulating intracellular oxidative stress levels [53]. Here, ALDH3A1 is linked to pancreatic neoplasm.